Action Potential Venture Capital

Dedicated to bringing bioelectronic medicines to patients.

About Us

APVC is a leading medical technology venture capital firm founded by GSK in 2013. We invest around the world and take a hands-on role on the boards of start-ups advancing bioelectronic medicines and their enabling technologies.

We believe in the fundamental advantage of an inclusive and diverse workspace and are committed to creating a more equitable healthcare investor and entrepreneurial community. Our commitment begins at APVC through the diversity of the investment team, and we extend this accountability to the companies we invest in.

What is Bioelectronic Medicine

Bioelectronic medicine is an emerging therapeutic field which leverages advances in hardware, computing and material science to regulate neural or cellular activity, and more effectively treat a range of chronic diseases.

One important therapeutic target for bioelectronic medicines is the nervous system which carries electrical impulses – or action potentials – that control virtually every organ or function in our bodies. The nervous system can be modulated to treat diseases through the targeted delivery of various forms of energy including electrical, electromagnetic, and acoustic energy.

  • Electric icon
  • Electromagnetic icon
  • Acoustic icon
Upload icon

Who we back

left brain

Who we are

Upload icon
Upload icon
10 October 2022

First Patient Enrolled in Stage 2 of Pivotal Study of Setpoint's Pioneering Technology for Rheumatoid Arthritis

News & Comments
read more
21 September 2022

MicroTransponder Completes $73M Series E Financing

News & Comments
read more
4 May 2022

Listen to Imran Eba Discussing APVC's Experience of Investing in Bioelectronic Medicines

News & Comments
read more
your details
upload a document
Upload icon
your message

This website and the contact information contained therein is not intended for reporting adverse events. If you have a question about a GSK product or want to report a side effect, please call the GSK Response Center at 1-888-825-5249. Monday-Friday, 8:00 am - 6:00 pm ET

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.